174 results
Page 5 of 9
8-K
EX-99.2
gcyqcg
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
5m60tg
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
b2gs7c
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
mm8 vzj9utg
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
DEFA14A
df8yi2jdf6a1 kdybf
29 Apr 20
Additional proxy soliciting materials
4:05pm
S-3ASR
EX-4.2
bd4ev6mqug
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
EX-4.2
tpefx1 uyh
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-1.1
qj6cn36
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
r2pomfi2lm2yovczz
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
kju hx1ph77kg13yn
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-99.2
uzt3 td8sr
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
EX-4.2
9nesyzs 6hen6
18 Mar 20
Automatic shelf registration
10:00pm
8-K
EX-99.1
dlq8 jek0dy
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm